Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Recruiting

Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients

NCT06505369

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Copenhagen University Hospital (Rigshospitalet) Copenhagen, Denmark

Odense University Hospital Odense, Denmark

Vejle hospital Vejle, Denmark

North Estonia Medical Centre Tallinn, Estonia

View Trial Details

Recruiting

Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM

NCT06503107

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients

NCT05636787

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Departement of Medical Oncology, University Hospital Berne Bern, Switzerland

View Trial Details

Recruiting

A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment

NCT06109233

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Recruiting

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

NCT06463717

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma

NCT06407947

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Juan Du Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

NCT04061512

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Royal United Hospital, Bath Bath, United Kingdom

The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth, United Kingdom

East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom

University Hospital of Wales Cardiff, United Kingdom

View all 25 locations

View Trial Details

Recruiting

Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma

NCT06149910

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: All4Cure Seattle, Washington, United States

View Trial Details

Recruiting

Daratumumab for Patients With Light Chain Amyloidosis

NCT06376214

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations: National Clinical Research Center for Kidney Diseases, Jinling Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.

NCT06232096

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Institute of Hematology and Blood Diseases Hospital Beijing, China

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions